» Articles » PMID: 23599318

Minimal Access Surgery Compared with Medical Management for Gastro-oesophageal Reflux Disease: Five Year Follow-up of a Randomised Controlled Trial (REFLUX)

Overview
Journal BMJ
Specialty General Medicine
Date 2013 Apr 20
PMID 23599318
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine the long term clinical effectiveness of laparoscopic fundoplication as an alternative to drug treatment for chronic gastro-oesophageal reflux disease (GORD).

Design: Five year follow-up of multicentre, pragmatic randomised trial (with parallel non-randomised preference groups).

Setting: Initial recruitment in 21 UK hospitals.

Participants: Responders to annual questionnaires among 810 original participants. At entry, all had had GORD for >12 months.

Intervention: The surgeon chose the type of fundoplication. Medical therapy was reviewed and optimised by a specialist. Subsequent management was at the discretion of the clinician responsible for care, usually in primary care.

Main Outcome Measures: Primary outcome measure was self reported quality of life score on disease-specific REFLUX questionnaire. Other measures were health status (with SF-36 and EuroQol EQ-5D questionnaires), use of antireflux medication, and complications.

Results: By five years, 63% (112/178) of patients randomised to surgery and 13% (24/179) of those randomised to medical management had received a fundoplication (plus 85% (222/261) and 3% (6/192) of those who expressed a preference for surgery and for medical management). Among responders at 5 years, 44% (56/127) of those randomised to surgery were taking antireflux medication versus 82% (98/119) of those randomised to medical management. Differences in the REFLUX score significantly favoured the randomised surgery group (mean difference 8.5 (95% CI 3.9 to 13.1), P<0.001, at five years). SF-36 and EQ-5D scores also favoured surgery, but were not statistically significant at five years. After fundoplication, 3% (12/364) had surgical treatment for a complication and 4% (16) had subsequent reflux-related operations-most often revision of the wrap. Long term rates of dysphagia, flatulence, and inability to vomit were similar in the two randomised groups.

Conclusions: After five years, laparoscopic fundoplication continued to provide better relief of GORD symptoms than medical management. Adverse effects of surgery were uncommon and generally observed soon after surgery. A small proportion had re-operations. There was no evidence of long term adverse symptoms caused by surgery.

Trial Registration: Current Controlled Trials ISRCTN15517081.

Citing Articles

Efficacy and safety of antireflux surgery in gastroesophageal-related cough: a systematic review and meta-analysis.

Liu Y, Huang J, Zhong S, Zheng Z, Xu Z, Zhou D Int J Surg. 2024; 111(1):1348-1356.

PMID: 39206849 PMC: 11745681. DOI: 10.1097/JS9.0000000000001998.


Current management of gastro-oesophageal reflux disease-treatment costs, safety profile, and effectiveness: a narrative review.

Lata T, Trautman J, Townend P, Wilson R Gastroenterol Rep (Oxf). 2023; 11:goad008.

PMID: 37082451 PMC: 10112961. DOI: 10.1093/gastro/goad008.


Longer-term outcomes of gastroesophageal reflux disease treated with magnetic sphincter augmentation.

Puri A, Steven S, Markar S, Boyle N Dis Esophagus. 2023; 36(10).

PMID: 36942526 PMC: 10789235. DOI: 10.1093/dote/doad014.


To the Editor: Reply to He J., Yin Y., Tang W., et al. Objective Outcomes of an Extended Anti-Reflux Mucosectomy in the Treatment of PPI-Dependent Gastroesophageal Reflux Disease (with Video). J Gastrointest Surg. 2022.

Wilson R J Gastrointest Surg. 2022; 27(2):466-468.

PMID: 36581763 DOI: 10.1007/s11605-022-05562-z.


Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable.

Razia D, Mittal S, Walia R, Tokman S, Huang J, Smith M Surg Endosc. 2022; 37(2):1114-1122.

PMID: 36131161 PMC: 9491650. DOI: 10.1007/s00464-022-09598-9.


References
1.
Roland M, Torgerson D . What are pragmatic trials?. BMJ. 1998; 316(7127):285. PMC: 2665488. DOI: 10.1136/bmj.316.7127.285. View

2.
Torgerson D, Sibbald B . Understanding controlled trials. What is a patient preference trial?. BMJ. 1998; 316(7128):360. PMC: 2665528. DOI: 10.1136/bmj.316.7128.360. View

3.
Nagelkerke N, Fidler V, Bernsen R, Borgdorff M . Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Stat Med. 2000; 19(14):1849-64. DOI: 10.1002/1097-0258(20000730)19:14<1849::aid-sim506>3.0.co;2-1. View

4.
Broeders J, Roks D, Jamieson G, Devitt P, Baigrie R, Watson D . Five-year outcome after laparoscopic anterior partial versus Nissen fundoplication: four randomized trials. Ann Surg. 2012; 255(4):637-42. DOI: 10.1097/SLA.0b013e31824b31ad. View

5.
Goeree R, Hopkins R, Marshall J, Armstrong D, Ungar W, Goldsmith C . Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation. Value Health. 2011; 14(2):263-73. DOI: 10.1016/j.jval.2010.09.004. View